PBH
NYSEPrestige Consumer Healthcare Inc.
News · 26 weeks45+167%
2026-01-252026-07-19
Mix3590d
- Insider19(54%)
- SEC Filings8(23%)
- Other4(11%)
- Earnings3(9%)
- Analyst1(3%)
Latest news
25 items- SECPrestige Consumer Healthcare Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits8-K - Prestige Consumer Healthcare Inc. (0001295947) (Filer)
- SECAmendment: Prestige Consumer Healthcare Inc. filed SEC Form 8-K: Financial Statements and Exhibits8-K/A - Prestige Consumer Healthcare Inc. (0001295947) (Filer)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Prestige Consumer Healthcare Inc.SCHEDULE 13G/A - Prestige Consumer Healthcare Inc. (0001295947) (Subject)
- SECPrestige Consumer Healthcare Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Prestige Consumer Healthcare Inc. (0001295947) (Filer)
- PRPrestige Consumer Healthcare Inc. Completes Acquisition of LaCorium Health, Prices $400 Million Senior Notes Offering, and Announces First Quarter Fiscal 2027 Earnings Results DateTARRYTOWN, N.Y., July 06, 2026 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) ("Prestige") today announced that it has closed the previously announced acquisition of LaCorium Health ("LaCorium"), priced a private offering of $400 million in senior notes, and will report its first quarter fiscal 2027 results on August 6, 2026. Completion of LaCorium Health Acquisition The Company completed the acquisition on July 1, 2026. The closing was finalized pursuant to the terms of the definitive agreement announced on May 13, 2026, under which Prestige agreed to acquire LaCorium for approximately $150 million in cash. The Company financed the transaction with cash on hand and exi
- PRPrestige Consumer Healthcare Inc. Announces Offering of $400 Million Senior NotesTARRYTOWN, N.Y., June 30, 2026 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) (the "Company") announced today that its wholly-owned subsidiary, Prestige Brands, Inc. ("Prestige Brands"), intends to offer, subject to market and other conditions, up to $400 million in aggregate principal amount of new senior notes due 2034 (the "notes") in a private offering. The notes will be senior unsecured obligations of Prestige Brands and will be guaranteed by the Company and certain of its domestic subsidiaries. The Company intends to use the net proceeds from the proposed offering, together with cash on hand, to redeem all $400 million of Prestige Brands’ outstanding 5.125% Senior
- SECAmendment: Prestige Consumer Healthcare Inc. filed SEC Form 8-K: Financial Statements and Exhibits8-K/A - Prestige Consumer Healthcare Inc. (0001295947) (Filer)
- SECSEC Form DEF 14A filed by Prestige Consumer Healthcare Inc.DEF 14A - Prestige Consumer Healthcare Inc. (0001295947) (Filer)
- SECPrestige Consumer Healthcare Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Creation of a Direct Financial Obligation, Other Events, Financial Statements and Exhibits8-K - Prestige Consumer Healthcare Inc. (0001295947) (Filer)
- PRPrestige Consumer Healthcare Inc Completes Acquisition of Breathe Right®TARRYTOWN, N.Y., June 15, 2026 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) ("Prestige") today announced that it has closed the previously announced acquisition of the Breathe Right® brand and certain other brands. The closing was finalized pursuant to the terms of the asset purchase agreement, announced on March 20, 2026, under which Prestige agreed to acquire the Breathe Right® brand and certain other brands from Foundation Consumer Healthcare for $1.045 billion, or approximately $900 million net of anticipated tax benefits valued at $150 million. Breathe Right®, created in the 1990s, is an iconic #1 brand synonymous with the nasal strip category. It will become the
- PRPrestige Consumer Healthcare Inc. to Participate in the Oppenheimer Annual Consumer Growth and E-Commerce ConferenceTARRYTOWN, N.Y., June 05, 2026 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will participate in a fireside chat at the Oppenheimer 26th Annual Consumer Growth and E-Commerce Conference virtually on Monday, June 8, 2026 at 9:45 a.m. ET. A live webcast of this event will be available at www.prestigeconsumerhealthcare.com under the "Investors" section and the "Events and Presentations" tab, or by using the following link: https://ir.prestigebrands.com/events-presentations/events For those unable to participate during the live webcast, a replay option will be available on the Company's website following the event. About Prestige Consumer Healthcar
- SECSEC Form 10-K filed by Prestige Consumer Healthcare Inc.10-K - Prestige Consumer Healthcare Inc. (0001295947) (Filer)
- INSIDERAmendment: CFO & COO Sacco Christine covered exercise/tax liability with 1,091 shares, decreasing direct ownership by 2% to 57,374 units (SEC Form 4)4/A - Prestige Consumer Healthcare Inc. (0001295947) (Issuer)
- ANALYSTPrestige Consumer downgraded by OppenheimerOppenheimer downgraded Prestige Consumer from Outperform to Perform
- SECPrestige Consumer Healthcare Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Prestige Consumer Healthcare Inc. (0001295947) (Filer)
- PRPrestige Consumer Healthcare Inc. Reports Fiscal 2026 Results, Announces Acquisition of LaCorium HealthReported revenues of $281.6 million in Q4 and $1,088.7 million in fiscal year 2026Diluted EPS of $3.91 and Adjusted Diluted EPS of $4.38 in fiscal year 2026Announces agreement to acquire LaCorium Health, a leader in Australian therapeutic skin careIntroducing Outlook for Fiscal 2027 Organic Revenue Growth and Adjusted Diluted EPS of 1% to 3%, respectively, excluding the impact of acquisitions TARRYTOWN, N.Y., May 13, 2026 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today reported financial results for its fourth quarter and fiscal year ended March 31, 2026. "Our fiscal 2026 demonstrated the resilience of our business model in a challenging consumer backdrop. Our div
- INSIDERSenior VP Operations Zerillo Jeffrey sold $18,350 worth of shares (351 units at $52.28), decreasing direct ownership by 0.83% to 41,810 units (SEC Form 4)4 - Prestige Consumer Healthcare Inc. (0001295947) (Issuer)
- INSIDERSenior VP Operations Zerillo Jeffrey sold $16,580 worth of shares (305 units at $54.36) and covered exercise/tax liability with 351 shares, decreasing direct ownership by 2% to 42,161 units (SEC Form 4)4 - Prestige Consumer Healthcare Inc. (0001295947) (Issuer)
- INSIDERCFO & COO Sacco Christine covered exercise/tax liability with 991 shares, decreasing direct ownership by 1% to 71,636 units (SEC Form 4)4 - Prestige Consumer Healthcare Inc. (0001295947) (Issuer)
- INSIDERChief Executive Officer Lombardi Ronald M. covered exercise/tax liability with 2,543 shares, decreasing direct ownership by 0.68% to 373,465 units (SEC Form 4)4 - Prestige Consumer Healthcare Inc. (0001295947) (Issuer)
- INSIDEREVP, Marketing & Sales Mekhail Adel covered exercise/tax liability with 487 shares, decreasing direct ownership by 2% to 25,703 units (SEC Form 4)4 - Prestige Consumer Healthcare Inc. (0001295947) (Issuer)
- INSIDERSenior VP Operations Zerillo Jeffrey covered exercise/tax liability with 307 shares and sold $66,373 worth of shares (1,207 units at $54.99), decreasing direct ownership by 3% to 42,820 units (SEC Form 4)4 - Prestige Consumer Healthcare Inc. (0001295947) (Issuer)
- INSIDERCFO & COO Sacco Christine covered exercise/tax liability with 1,267 shares, decreasing direct ownership by 2% to 72,627 units (SEC Form 4)4 - Prestige Consumer Healthcare Inc. (0001295947) (Issuer)
- INSIDERChief Executive Officer Lombardi Ronald M. covered exercise/tax liability with 2,197 shares, decreasing direct ownership by 0.58% to 376,008 units (SEC Form 4)4 - Prestige Consumer Healthcare Inc. (0001295947) (Issuer)
- INSIDERCFO & COO Sacco Christine was granted 18,984 shares and covered exercise/tax liability with 3,434 shares, increasing direct ownership by 27% to 73,894 units (SEC Form 4)4 - Prestige Consumer Healthcare Inc. (0001295947) (Issuer)
PBH FAQ
7 questionsWhat does Prestige Consumer Healthcare Inc. do?
Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) healthcare products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's analgesic powders, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids and lozenges, Clear Eyes for eye allergies/redness relief, Compound W wart removals, Debrox ear wax removals, DenTek for PEG oral care, and Dramamine for motion sickness relief...Where does PBH stock trade?
Prestige Consumer Healthcare Inc. (PBH) is listed on NYSE.What sector and industry is PBH in?
Prestige Consumer Healthcare Inc. operates in the Health Care sector, Biotechnology: Pharmaceutical Preparations industry.When did Prestige Consumer Healthcare Inc. go public?
Prestige Consumer Healthcare Inc. (PBH) completed its IPO in 2005.What are analysts saying about PBH?
Prestige Consumer Healthcare Inc. has had 8 recent analyst actions on file. The most recent action was from Oppenheimer: Perform on 2026-05-14.What companies are similar to PBH?
Notable peers in the same industry include LLY (Eli Lilly and Company), JNJ (Johnson & Johnson), ABBV (AbbVie Inc.), MRK (Merck & Company Inc.), NVS (Novartis AG). Compare PBH side-by-side with any of them on Quantisnow.How can I track PBH on Quantisnow?
Quantisnow aggregates Prestige Consumer Healthcare Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow PBH to receive live email and push alerts on every new disclosure.